Recent Progress Anticipated Upcoming Milestones Present updated Phase 2 data showing palazestrant in combination with ribociclib at the San Antonio ... nuclear receptors, and mechanisms of acquired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback